We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Polypure Introduces Key Monodispersed Peg Compound
Product News

Polypure Introduces Key Monodispersed Peg Compound

Polypure Introduces Key Monodispersed Peg Compound
Product News

Polypure Introduces Key Monodispersed Peg Compound


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Polypure Introduces Key Monodispersed Peg Compound"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Polypure has launched its latest monodispersed PEG derivative – Maleimidopropionyl-PEG NHS ester. This heterobifunctional PEG is designed to improve crosslinking between compounds carrying amino groups and thiol functions and is attracting widespread interest from both diagnostic and pharmaceutical developers.

According to Polypure Marketing Director Magali Le Bomin, this new PEG fully demonstrates the increasingly acknowledged benefits of monodispersed PEGs: “The polymer homogeneity achieved by using our patented Sample Displacement Chromatographic purification method ensures a high level of functional integrity."

"Likewise, the single molecular weight avoids the characterization problems of polydispersed polymer mixtures. Looking at applications, for diagnostics we can significantly improve cross-linking, binding and lots reproducibility. Similarly for pharmaceuticals, the extended PEG space length enhances the solubility of poorly soluble drugs," Bomin continued. 

"Furthermore, there is the overriding benefit of being able to reduce diagnostic and drug design complexity which has a significant impact on development, regulatory and production times.”

Advertisement